Thomas Münzel

Showing 1-12 of 12 articles

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier A, Buono A, Serruys P, Sabaté M

March 20, 2020 | 10.4244/EIJ-D-19-00773

Interventions for valvular disease

Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants

von Bardeleben R, Hobohm L, Kreidel F, Ostad MA, Schulz E, Konstantinides S, Lankeit M, Feldman T, Münzel T, Keller K

April 16, 2019 | 10.4244/EIJ-D-18-00961

Characteristics and outcome of patients with complex coronary lesions treated with bioresorbable scaffolds: three-year follow-up in a cohort of consecutive patients

Anadol R, Lorenz L, Weissner M, Ullrich H, Polimeni A, Münzel T, Gori T

October 12, 2018 | 10.4244/EIJ-D-17-00410

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

Nef H, Wiebe J, Kastner J, Mehilli J, Münzel T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm C

December 20, 2017 | 10.4244/EIJ-D-17-00330

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R

Mehilli J, Achenbach S, Wöhrle J, Baquet M, Riemer T, Münzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C, Wöhrle J, Richardt G

December 20, 2017 | 10.4244/EIJ-D-17-00291

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabaté M, Tamburino C, Nef H, Gori T

October 11, 2017 | 10.4244/EIJ-D-16-00568

Coronary interventions

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S

April 20, 2017 | 10.4244/EIJ-D-16-00974

Coronary interventions

Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry

Gori T, Wiebe J, Capodanno D, Latib A, Lesiak M, Pyxaras S, Mehilli J, Caramanno G, Di Mario C, Brugaletta S, Weber J, Capranzano P, Sabaté M, Mattesini A, Geraci S, Naber C, Araszkiewicz A, Colombo A, Tamburino C, Nef H, Münzel T

August 5, 2016 | 10.4244/EIJY15M09_10

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C

February 20, 2015 | 10.4244/EIJY14M07_11

Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes

Gori T, Schulz E, Hink U, Wenzel P, Post F, Jabs A, Münzel T

January 20, 2014 | 10.4244/EIJV9I9A176

The impact of gender on fractional flow reserve measurements

Fineschi M, Guerrieri G, Orphal D, Palmerini E, Münzel T, Warnholtz A, Pierli C, Gori T

July 26, 2013 | 10.4244/EIJV9I3A58

How should I treat a patient with typical angina, typical angiography, negative FFR?

Jabs A, Hink U, Fineschi M, Münzel T, Gori T

May 21, 2013 | 10.4244/EIJV9I1A22

Latest news

NEW ISSUE

Challenging TAVI anatomies, risk prediction for PCI of CTOs, antithrombotic strategies, and more

April 3, 2020

JAA

NEW ahead of print: FFR and myocardial mass

Post atrioventricular (AV) branch intervention coronary angiogram

April 8, 2020

Editorial

CTO Percutaneous Coronary Intervention Scores: Present and Future

Evangelia Vemmou

April 8, 2020

Trials Book

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

Cardiocerebral Continuum in Cognitive Function After TAVI

Rodrigo Bagur

April 3, 2020

JAA

This week’s JAA’s: Coronary Bifurcation in Asia Pacific, 3year outcomes: Compare-ACUTE...

Thomas Münzel

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke